PolyI:C-Induced, TLR3/RIP3-Dependent Necroptosis Backs Up Immune Effector-Mediated Tumor Elimination In Vivo.
about
Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapyCancer therapy in the necroptosis eraAdjuvant for vaccine immunotherapy of cancer--focusing on Toll-like receptor 2 and 3 agonists for safely enhancing antitumor immunityThe Absence of Interferon-β Promotor Stimulator-1 (IPS-1) Predisposes to Bronchiolitis and Asthma-like Pathology in Response to Pneumoviral Infection in MiceTherapy-induced microenvironmental changes in cancer.Cancer and necroptosis: friend or foe?Relevance of necroptosis in cancer.Necroptosis in cancer: An angel or a demon?Necroptosis: Mechanisms and Relevance to Disease.Reassessing the role of NAD as a prosurvival factor.Double-stranded RNA promotes CTL-independent tumor cytolysis mediated by CD11b+Ly6G+ intratumor myeloid cells through the TICAM-1 signaling pathway.Tumor cell death by pattern-sensing of exogenous RNA: Tumor cell TLR3 directly induces necroptosis by poly(I:C) in vivo, independent of immune effector-mediated tumor shrinkage.Basic understanding and therapeutic approaches to target toll-like receptors in cancerous microenvironment and metastasis.Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses.Necroptotic cell death in anti-cancer therapy.Molecular Cell Biology of Apoptosis and Necroptosis in Cancer.Local Activation of p53 in the Tumor Microenvironment Overcomes Immune Suppression and Enhances Antitumor Immunity.Release of c-FLIP brake selectively sensitizes human cancer cells to TLR3-mediated apoptosis
P2860
Q26739959-29F11221-5A5C-42A8-A437-8EDD33E51570Q26766339-D5870E6D-4639-49BF-9150-521B92C60813Q26782131-27C5CB14-D7AB-4BC8-AC35-DFAD497ABE83Q33725605-110A3FA4-E3F3-4C8C-9F21-77C2853B1164Q38756772-FEFF6862-BA5F-4AB0-B77A-9B5C56E5EB8CQ38799139-27C47B47-3DCA-4AC7-9C2A-B3A8CD60ADE6Q39030578-AEEC21C8-0DD3-4CA3-AAAB-7935B56A3CBAQ39398933-CBABC531-CD7B-4132-AA4E-FFDC608F9D4CQ40411907-A1C83D91-2ACD-46C1-86D4-F3142056F682Q40632295-FF5FFC89-0B92-4BA1-8E00-38F9D7DE758FQ46461063-7BA5A3A5-2E0B-46BE-9A91-F66267CFD341Q47113328-B0AFAFD6-37B7-44E6-9A1E-30AA5C180F88Q47250120-186B36A3-E0C7-48A8-86EE-B0BD508143D9Q47614555-721FC989-7435-4046-AAEF-D2B4DC1B5D53Q47659073-2A7400B8-956A-4201-B0DC-F0BEFDC9F1FEQ50221065-5DBAF97C-289D-4249-8032-315F4ED5A996Q50676824-ADB61F39-632B-44DE-BE37-C80EC16FD238Q58695329-76A69EDB-15AD-47DC-B80E-07A07BE81DB0
P2860
PolyI:C-Induced, TLR3/RIP3-Dependent Necroptosis Backs Up Immune Effector-Mediated Tumor Elimination In Vivo.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
PolyI:C-Induced, TLR3/RIP3-Dep ...... ted Tumor Elimination In Vivo.
@en
type
label
PolyI:C-Induced, TLR3/RIP3-Dep ...... ted Tumor Elimination In Vivo.
@en
prefLabel
PolyI:C-Induced, TLR3/RIP3-Dep ...... ted Tumor Elimination In Vivo.
@en
P2093
P1476
PolyI:C-Induced, TLR3/RIP3-Dep ...... ated Tumor Elimination In Vivo
@en
P2093
Hiromi Takaki
Hiroyuki Oshiumi
Misako Matsumoto
Ryo Takemura
Seiji Okada
Takanori Teshima
Takashi Akazawa
Tsukasa Seya
P304
P356
10.1158/2326-6066.CIR-14-0219
P50
P577
2015-04-21T00:00:00Z